Researchers review decades of progress in human cytomegalovirus (HCMV) vaccine development, emphasizing challenges, ...

Shares of Moderna Inc. MRNA inched 0.92% higher to $42.57 Monday, on what proved to be an all-around mixed trading session ...

Moderna shares are trading higher by 3.1% Monday afternoon. The CDC reported a significant rise in acute respiratory ...

Trudeau has faced calls to step down amid polls showing his ruling Liberal Party would be swept out of power in the next election.

Dec. 18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers blood sugar, works. A study provided direct evidence in mice that it ...

In the latest trading session, Moderna (MRNA) closed at $42.18, marking a +0.43% move from the previous day. This change lagged the S&P 500's 1.26% gain on the day. Elsewhere, the Dow saw an upswing ...

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

Jan. 3, 2025 — Scientists recently discovered that the giant 'conveyer belt' currents that push star-forged material out of our galaxy and pull it back in can also transport carbon atoms. That ...